Tuesday, May 19, 2020
Get the Morning Brief sent directly to your inbox every Monday to Friday by 6:30 a.m. ET.
You don’t have to be an epidemiologist to be bullish on stocks
The stock market surged on Monday, with the Dow (^DJI) jumping 911 points or 3.9%. And at least some of the rally was attributed to improved hopes that a coronavirus vaccine was on the horizon.
Biotech firm Moderna (MRNA) announced encouraging interim Phase 1 data on its vaccine candidate.
“The Moderna team continues to focus on moving as fast as safely possible to start our pivotal Phase 3 study in July and, if successful, file a [Biologics Lisence Application],” CEO Stéphane Bancel said. “We are investing to scale up manufacturing so we can maximize the number of doses we can produce to help protect as many people as we can.”
Moderna shares jumped 20%.
While it’s historically taken at least five years to get a vaccine, extraordinary efforts are being made to achieve a vaccine in a fraction of that time.
And according to a recent survey conducted by Deutsche Bank, financial market professionals are betting we’ll get that vaccine sooner than later.
“In terms of the virus, people are generally optimistic (74%) on a vaccine being available within 18 months even if only 5% think within six months,” Deutsche Bank’s Jim Reid reported on Monday.
Market pros are bullish on the COVID-19 vaccine timeline. (Deutsche Bank)
This is incrementally encouraging as many agree that a vaccine is a prerequisite for getting things back to where they were before the coronavirus pandemic.
“For the economy to fully recover, people will have to be fully confident,” Fed Chair Jerome Powell said on CBS’s “60 Minutes.” “And that may have to await the arrival of a vaccine.”
But while Monday’s developments are hopeful, there’s still a long way to go. And everyone may need to better manage their expectations.
Even assuming a vaccine soon becomes available, it’ll take a considerable ramp up before we have the capacity to get the billions of doses that are needed. No one company can do this.
“To address the potential demand, companies are scaling-up manufacturing at-risk without clear evidence that the vaccine is safe and efficacious,” Morgan Stanley analysts wrote on Sunday. “Ensuring quality is one of the main challenges, along with establishing a reliable distribution system and meeting cold chain requirements.”
In other words, there’s much more to it than manufacturing the vaccines themselves.
“Every day, it’s, OK, are we going to run out of glass vials?” Bill Gates said in an interview with the Wall Street Journal. “You may think that’s a simple part of it, but nobody’s ever made 7 billion vaccines.”
By Sam Ro, managing editor. Follow him at @SamRo
What to watch today
8:30 a.m. ET: Building Permits, April (1 million expected, 1.350 in March); Building Permits month-on-month, April (-25.9% expected, -7.0% in March)
8:30 a.m. ET: Housing Starts, April (929,000 expected, 1.216 million in March)
6 a.m. ET: Home Depot (HD) is expected to report adjusted earnings of $2.25 per share on $27.63 billion in revenue
6 a.m. ET: Walmart (WMT) is expected to report adjusted earnings of $1.13 per share on $132.5 billion in revenue
7 a.m. ET: Kohl’s (KSS) is expected to report an adjusted loss of $1.88 per share on $2.21 billion in revenue
Other notable reports: Advance Auto Parts (AAP)
Trump threatens permanent freeze of WHO funding [Reuters]
UK unveils new post-Brexit global trade tariff regime [Yahoo Finance UK]
Disney’s Mayer to become TikTok CEO [Reuters]
Nasdaq set to tighten listing rules, impacting Chinese IPOs [Bloomberg]
YAHOO FINANCE HIGHLIGHTSJ.C. Penney bankruptcy aftermath: 700 very large stores may completely vanish
Larry Summers: Pandemic marks a ‘fairly profound structural change’ in economy
47% of people will visit restaurants ‘as soon as they reopen:’ Piper Sandler
Follow Yahoo Finance on Twitter, Facebook, Instagram, Flipboard, SmartNews, LinkedIn, YouTube, and reddit.
Find live stock market quotes and the latest business and finance news
For tutorials and information on investing and trading stocks, check out Cashay